SINGAPORE, May 10, 2017 /PRNewswire/ -- The molecular diagnostics (MDx) market in the Asia-Pacific
"Companies aiming to enter APAC or expand regionally have to devise tailor-made strategies for successful market penetration. They should actively seek out joint ventures and strategic partnerships to gain wider market share and remain sustainable in a tech-driven industry," said Transformational Health Industry Analyst M Shaillender. "Early movers such as Qiagen have succeeded with viable business opportunities and solid revenue returns."
APAC Molecular Diagnostics Market, Forecast to 2021, a recent research from Frost & Sullivan's Life Sciences Growth Partnership Service program, examines the APAC MDx market and identifies growth segments, trends driving adoption, and strategic measures taken by market majors such as Roche, Thermofisher, Qiagen and Sysmex. The market, which stood at US$1.72 billion in 2016, is expected to generate US$2.86 billion by 2021, growing at a compound annual growth rate (CAGR) of 10.7 percent.
Click here for complimentary access to more information on this analysis and to register for a Growth Strategy Dialogue, a free interactive briefing with Frost & Sullivan's thought leaders.
China and India will drive the future of the APAC MDx market, with tremendous growth opportunities gaining prominence in the global pharmaceutical industry. Other developments in the APAC MDx market include:
"MDx tests for oncology diagnostics and pharmacogenomics are key areas to watch as they redefine treatment and expand the panel of diagnostics toward particular diseases, leading to personalized medicine," observed Shaillender.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Contact us: Start the discussion
APAC Molecular Diagnostics Market, Forecast to 2021 P92E-52
Contact: Carrie Low Corporate Communications Asia-Pacific P: +603 6204 5910 F: +603 6201 7402 E: email@example.com
Melissa Tan Corporate Communications Asia-Pacific P: +65 6890 0926 F: +65 6890 0999 E: firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innovative-solutions-drive-double-digit-growth-opportunities-in-asia-pacific-molecular-diagnostics-market-300455798.html
SOURCE Frost & Sullivan
Subscribe to our Free Newsletters!
Tourette syndrome (TS) is a neurological disorder wherein the affected person makes repetitive and ...
Some drugs or therapeutic agents cause undesirable reactions in lungs, known as drug-induced ...
Sleep disorders are collectively known as ''Somnipathy.'' There are over 70 different medically ...View All